Infectious diseases once considered vanquished in the developed world now represent a growing challenge to public health care systems. Not only do we face threats from new diseases such as AIDS, MRSA, SARS and Avian Flu, but old scourges such as tuberculosis are returning in drug resistant forms. Food-borne infections are common, encompassing both common bacterial infections that are associated with gastro-enteritis and new diseases that have crossed the species barriers, such as BSE and the resultant new variant CJD. SARS and Avian Flu are the newest threats and have an increasingly high public profile. These diseases present complex and as yet unresolved problems for those involved in the control of infectious disease.
Jennifer Roberts and her international team present the contribution economists can make to the management and control of infectious diseases. The book leads the reader through the economic evaluation of specific diseases, chosen to reflect some of the great challenges to those aiming to control infectious disease in both developed and developing countries. It then examines the wider issues involved in the economics of infectious disease; modelling, governance and the control of outbreaks, risk assessment models for food safety, the global perspective and the role of international regulatory co-operation, and the effect on trade.
Contagion is an ever-present threat to public safety, particularly high on the international policy agenda in the current climate of fears of bioterrorism and the return of diseases thought eradicated. This introduction to the methods and techniques of economics as applied to infectious diseases will make fascinating reading for those involved from both perspectives, and is a timely contribution to a major issue.
1. Introduction to economics of infectious disease , Jennifer A. Roberts 2. Choosing the first line drug for malaria treatment - how can cost-effectiveness analysis inform policy? , Catherine Goodman, Salim Abdulla, Paul Coleman, Godfrey Mubyazi, Nassor Kikumbih, Tuoyo Okorosobo & Anne Mills 3. Economic issues related to antimicrobial resistance , Ramanan Laxinarayan 4. Economic evaluation of HIV prevention activities: dynamic challenges for cost-effectiveness analysis , Lilani Kumaranayake, Charlotte Watts, Peter Vickerman & Fern Terris-Prestholt 5. Modelling the cost-effectiveness of the new interventions: how can technological change be incorporated? , Richard Grieve 6. Complexity and the attribution of cost to hospital acquired infection , Nicholas Graves & Diana Weinhold 7. Decision analysis of strategies to deal with non- compliance with TB treatment , Joao G. Q. Costa, Laura C. Rodrigues, Andreia C. Santos & Maurice L. Barreto 8. Economic evaluations of HAI , Ros Plowman 9. The socio-economic burden of influenza: costs of illness and "willingness to pay" in a publicly funded health care system , Punam Mangtani & Amishi Shah 10. Willingness to pay for insecticide-treated nets in Surat, India , Mrigesh Bhatia & Julia Fox-Rushby 11. Disentangling value: assessing the benefits of containing antimicrobial resistance , Joanna Coast, Richard Smith & Michael Millar 12. Economics of animal health: implications for public health , Ana Riviere-Cinnamond 13. Economic analysis, and food safety risk assessment models , Tanya Roberts 14. Governance and the control of outbreaks , Azermeen Jamasi-Pavri 15. Governance arrangements for the control of infectious disease , Pauline Allen & Bronwyn Croxson 16. Evaluating U.S. regulations for food safety issues, using benefit and cost information , Jean Buzby, Felix Spinelli & Clark Nardinelli 17. Global governance of international public health: the role of international regulatory cooperation , Liliani Kumaranayake 18. Trade and infectious disease outbreaks: ensuring public health without comprising free trade , Vasant Narasimhan 19. Epilogue: applications of economics to contemporary concerns: MRSA and Avian Flu , Jennifer A. Roberts
(0 Comentarios)
